13-48379594-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000321.3(RB1):c.1333C>T(p.Arg445*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000321.3 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1333C>T | p.Arg445* | stop_gained, splice_region_variant | 14/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.1333C>T | p.Arg445* | stop_gained, splice_region_variant | 14/27 | NP_001394094.1 | ||
RB1 | NM_001407166.1 | c.1333C>T | p.Arg445* | stop_gained, splice_region_variant | 14/17 | NP_001394095.1 | ||
LOC112268118 | XR_002957522.2 | n.40+241G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1333C>T | p.Arg445* | stop_gained, splice_region_variant | 14/27 | 1 | NM_000321.3 | ENSP00000267163.4 | ||
RB1 | ENST00000650461.1 | c.1333C>T | p.Arg445* | stop_gained, splice_region_variant | 14/27 | ENSP00000497193.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248914Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 135036
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1459970Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 726232
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine | May 20, 2024 | Case and Pedigree Information: BILATERAL CASES:9, UNILATERAL CASES:5, TOTAL CASES:14, PEDIGREES:14. ACMG Codes Applied:PVS1, PM2, PS4M - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 21, 1989 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Jun 17, 2016 | This is a nonsense alteration in which a C is replaced by a T at coding position 1333 and is predicted to change an Arginine at codon 445 to a premature stop codon. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change creates a premature translational stop signal (p.Arg445*) in the RB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant is present in population databases (rs3092891, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with retinoblastoma (PMID: 2594029, 20447117, 22328814, 22963398, 26787237). ClinVar contains an entry for this variant (Variation ID: 13071). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 29261756, 34190019, 22328814, 26787237, 34294096, 2594029) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The p.R445* pathogenic mutation (also known as c.1333C>T), located in coding exon 14 of the RB1 gene, results from a C to T substitution at nucleotide position 1333. This changes the amino acid from an arginine to a stop codon within coding exon 14. This mutation has been detected in multiple individuals with retinoblastoma (Yandell DW et al. N. Engl. J. Med., 1989 Dec;321:1689-95; Richter S et al. Am J Hum Genet, 2003 Feb;72:253-69; Abouzeid H et al. Mol. Vis., 2007 Sep;13:1740-5; Dommering CJ et al. Fam Cancer, 2012 Jun;11:225-33; Seo SH et al. Clin Genet, 2013 May;83:494-6; He MY et al. Mol Vis, 2014 Apr;20:545-52; Dommering CJ et al. J Med Genet, 2014 Jun;51:366-74; Niederst MJ et al. Nat Commun, 2015 Mar;6:6377; Sagi M et al. Fam Cancer, 2015 Sep;14:471-80; Zhang J et al. N Engl J Med, 2015 Dec;373:2336-2346; Meric-Bernstam F et al. Ann Oncol, 2016 05;27:795-800; Singh J et al. Mol Vis, 2016 Aug;22:1036-47; Shahraki K et al. Eye (Lond), 2017 Apr;31:620-627; Tomar S et al. PLoS ONE, 2017 Jun;12:e0178776; Parma D et al. PLoS ONE, 2017 Dec;12:e0189736; Chaussade A et al. Eur J Med Genet, 2019 Mar;62:217-223; Lan X et al. Front Genet, 2020 Mar;11:142; Gupta H et al. BMC Med Genomics, 2021 Jul;14:188). Of note, this alteration is also designated as 1462C>T in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Malignant tumor of urinary bladder;C0035335:Retinoblastoma;C0149925:Small cell lung carcinoma;C0585442:Bone osteosarcoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 22, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at